05/15/12 Location : TBA
Business meeting to consider the nominations of Frank Kendall III, of Virginia, to be Under Secretary for Acquisition, Technology, and Logistics, James N. Miller, Jr., of Virginia, to be Under Secretary for Policy, Erin C. Conaton, of the District
of Columbia, to be Under Secretary for Personnel and Readiness, Kathleen H. Hicks, of Virginia, to be Principal Deputy Under Secretary for Policy, Jessica Lynn Wright, of Pennsylvania, to be Assistant Secretary for Reserve Affairs, Derek H. Chollet,
of Nebraska, to be Assistant Secretary for International Security Affairs, and Heidi Shyu, of California, to be Assistant Secretary of the Army for Acquisition, Logistics, and Technology, all of the Department of
Defense.
05/15/12 4:00 PMLocation : SD-192
Business meeting to markup proposed budget estimates for fiscal year 2013 for the Department of Homeland
Security.
05/15/12 3:30 PMLocation : SD-192
Business meeting to markup proposed budget estimates for fiscal year 2013 for the Department of Homeland
Security.
05/15/12 2:30 PMLocation : SH-219
Closed hearings to examine certain intelligence
matters.
Location : SD-562
Hearings to examine solving the long-term unemployment crisis for older
workers.
05/15/12 2:15 PMLocation : SD-562
Hearings to examine solving the long-term unemployment crisis for older
workers.
05/15/12 2:00 PMLocation : RHOB-2203
To receive a briefing on political prisoners in Central Asia, focusing on Uzbekistan, Turkmenistan, Kyrgyzstan, Tajikistan, and
Kazakhstan.
05/15/12 11:00 AMLocation : SD-138
Business meeting to markup proposed budget estimates for fiscal year 2013 for Military Construction and Veteran Affairs, and Related
Agencies.
05/15/12 10:00 AMLocation : SD-215
Hearings to examine tax reform, focusing on what it could mean for tribes and
territories.
Location : SD-430
Hearings to examine the cost of HIV/AIDS drugs and the Prize Fund alternative, including S.1137, to provide incentives for investment in research and development for new medicines, to enhance access to new medicines, and S.1138, to de-link research
and development incentives from drug prices for new medicines to treat HIV/AIDS and to stimulate greater sharing of scientific
knowledge.
